Thomas M. Keck

Has grant

Associate Professor, Dept. Chair

Rowan University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

U-Rise at Rowan University

Open Date: 2021-04-01

Close Date: 2026-03-31

Grant: Close

Low-Efficacy Dopamine D4 Receptor Partial Agonists for Cocaine Addiction

Open Date: 2020-09-30

Close Date: 2023-08-31

Grant: Close

Abuse liability and anti-addiction potential of the atypical mu opioid receptor agonist IBNtxA

Open Date: 2017-04-01

Close Date: 2018-03-31

Grant: Close

Low-Efficacy Dopamine D4 Receptor Partial Agonists for Cocaine Addiction

Open Date:

Close Date:

Articles (11)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (9)

Alessandro Piergentili

University of Camerino

ITALY

View details

Fabio Del Bello

University of Camerino

ITALY

View details

Joseph Lizza

University of Pittsburgh

UNITED STATES

View details

Estefanía Moreno

Professor and Researcher

University of Barcelona

SPAIN

View details

Chun Wu

UNITED STATES

View details

Comfort Boateng

Assistant Professor

UNITED STATES

View details

Gianfabio Giorgioni

Assistant Professor

University of Camerino

ITALY

View details

Henriette van Praag

Associate Professor

UNITED STATES

View details

Verònica Casadó-Anguera

University of Barcelona

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas M. Keck

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (11)

The CB1 negative allosteric modulator PSNCBAM-1 reduces ethanol self-administration via a nonspecific hypophagic effect

Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder

Decoding brain memory formation by single-cell RNA sequencing.

Functional and pharmacological role of the dopamine D<sub>4</sub> receptor and its polymorphic variants.

Assessing the synergistic effects of morphine and MP-III-024 co-administration: enhanced antinociception with reduced side effects

Novel Dopamine D4 Receptor-Selective Antagonists For Neuropsychiatric Disorders

Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D3 Receptor-Selective or Multitarget Bitopic Ligands Potentially Useful for Central Nervous System Disorders

Synergistic antihyperalgesic and antinociceptive effects of morphine and methyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate (MP-III-024): a positive allosteric modulator at α2GABA<sub>A</sub> and α3GABA<sub>A</sub> receptors.

Abuse Liability, Anti-Nociceptive, and Discriminative Stimulus Properties of IBNtxA

Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist

Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms.

Collaborators (9)

Alessandro Piergentili

Fabio Del Bello

Joseph Lizza

Estefanía Moreno

Chun Wu

Comfort Boateng

Gianfabio Giorgioni

Henriette van Praag

Verònica Casadó-Anguera

Make your next move.